المؤلفون: Soo, R.A., Han, J.Y., Dafni, U., Cho, B.C., Yeo, C.M., Nadal, E., Carcereny, E., de Castro, J., Sala, M.A., Bernabé, R., Coate, L., Provencio Pulla, M., Garcia Campelo, R., Cuffe, S., Hashemi, SMS, Früh, M., Massuti, B., Garcia-Sanchez, J., Dómine, M., Majem, M., Sanchez-Torres, J.M., Britschgi, C., Pless, M., Dimopoulou, G., Roschitzki-Voser, H., Ruepp, B., Rosell, R., Stahel, R.A., Peters, S.

المساهمون: ETOP 10-16 BOOSTER Collaborators, Stahel, R., Peters, S., Soo, R., Han, J.Y., Früh, M., Provencio, M., Coate, L., Dafni, U., Hiltbrunner, A., Ruepp, B., Roschitzki-Voser, H., Gasca-Ruchti, A., Giacomelli, N., Kammler, R., Marti, N., Nobs, L., Pardo-Contreras, M., Pfister, R., Piguet, A.C., Ribeli-Hofmann, S., Martinez, V.R., Roux, S., Sanchez-Hohl, M., Schneider, M., Schweri, R., Troesch, S., Zigomo, I., Tsourti, Z., Zygoura, P., Kassapian, M., Vervita, K., Dimopoulou, G., Andriakopoulou, C., Fernandez, M., Pereira, E., Simona, C., Tucker, L., Burnes, J., Barrett, A., McGrillen, M., Berset, C., Biaggi, C., Reist, M., Rentsch, P., Cuffe, S., Hashemi, S., Nadal, E., Carcereny, E., de Castro, J., Sala, M.A., Reyes, B., Pulla, M.P., Campelo, R.G., Massutí, B., Garcia, J., Dómine, M., Majem, M., Sanchez, J.M., Britschgi, C., Pless, M., Yeo, C.M., Cho, B.C.

المصدر: Annals of oncology, vol. 33, no. 2, pp. 181-192

مصطلحات موضوعية: EGFR mutations, NSCLC, bevacizumab, osimertinib, randomised controlled trial

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34839016; info:eu-repo/semantics/altIdentifier/eissn/1569-8041; https://serval.unil.ch/notice/serval:BIB_6A6669A4204FTest; urn:issn:0923-7534

الإتاحة: https://doi.org/10.1016/j.annonc.2021.11.010Test
https://serval.unil.ch/notice/serval:BIB_6A6669A4204FTest

المؤلفون: Rosell, R, Dafni, U, Felip, E, Curioni-Fontecedro, A, Gautschi, O, Peters, S, Massutí, B, Palmero, R, Aix, SP, Carcereny, E, Früh, M, Pless, M, Popat, S, Kotsakis, A, Cuffe, S, Bidoli, P, Favaretto, A, Froesch, P, Reguart, N, Puente, J, Coate, L, Barlesi, F, Rauch, D, Thomas, M, Camps, C, Gómez-Codina, J, Majem, M, Porta, R, Shah, R, Hanrahan, E, Kammler, R, Ruepp, B, Rabaglio, M, Kassapian, M, Karachaliou, N, Tam, R, Shames, DS, Molina-Vila, MA, Stahel, RA, BELIEF collaborative group

المساهمون: Popat, Sanjay, Marsden

مصطلحات موضوعية: BELIEF collaborative group, Humans, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Disease-Free Survival, Mutation, International Cooperation, Aged, Middle Aged, Female, Male, Intention to Treat Analysis, Response Evaluation Criteria in Solid Tumors, ErbB Receptors, Bevacizumab, Erlotinib Hydrochloride, Proof of Concept Study

وصف الملف: Print-Electronic; 444; image/png

العلاقة: The Lancet. Respiratory medicine, 2017, 5 (5), pp. 435 - 444; https://repository.icr.ac.uk/handle/internal/1190Test

الإتاحة: https://doi.org/10.1016/s2213-2600Test(17)30129-7
https://repository.icr.ac.uk/handle/internal/1190Test

المؤلفون: De Castro, J., González-Larriba, J., Vázquez, S., Massutí, B., Sanchez-Torres, J., Dómine, M., Garrido, P., Calles, A., Artal, A., Collado, R., García, R., Sereno, M., Majem, M., Macías, J., Juan, O., Gómez-Codina, J., Hernández, B., Lázaro, M., Ortega, A., Cobo, M.

المصدر: Clinical & Translational Oncology; Feb2017, Vol. 19 Issue 2, p219-226, 8p

المؤلفون: Abad, A¹, Martínez-Balibrea, E² embalibrea@iconcologia.net, Viéitez, J M³, Alonso-Orduña, V⁴, Alfonso, P García⁵, Manzano, J L¹, Massutí, B⁶, Benavides, M⁷, Carrato, A⁸, Zanui, M⁹

المصدر: Annals of Oncology. Feb2018, Vol. 29 Issue 2, p439-444. 6p. 1 Diagram, 2 Charts, 1 Graph.

مصطلحات موضوعية: *COLON cancer, *METASTASIS, *CANCER patients, *OXALIPLATIN, *ANTINEOPLASTIC agents

المؤلفون: Garcia-Alfonso, Pilar, Chaves, Manuel, Muñoz, Andrés, Salud, Antonieta, García-Gonzalez, Maria, Grávalos, Cristina, Massuti, Bartomeu, González-Flores, Encarna, Queralt, Bernardo, López-Ladrón, Amelia, Losa, Ferran, Gómez, Maria Jose, Oltra, Amparo, Aranda, Enrique

المساهمون: Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD), Garcia-Alfonso,P, Muñoz,A Servicio de Oncología, Hospital Universitario Gregorio Marañón, Madrid, Spain. Chaves,M Servicio de Oncología, Hospital Virgen del Rocío, Sevilla, Spain. Salud,A Servicio de Oncología, Hospital Lleida Arnau de Vilanova, Barcelona, Spain. García-González,M Servicio de Oncología, Hospital Universitario de Burgos, Burgos, Spain. Grávalos,C Servicio de Oncología, Hospital 12 Octubre, Madrid, Spain. Massuti,B Servicio de Oncología, Hospital General Universitario, Alicante, Spain. González-Flores,E Servicio de Oncología, Hospital Virgen de las Nieves, Granada, Spain. Queralt,B Servicio de Oncología, ICO. Hospital. Josep Trueta, Gerona, Spain. López-Ladrón,A Servicio de Oncología, Hospital Nuestra Señora de Valme, Sevilla, Spain. Losa,F Servicio de Oncología, Hospital General de L’Hospitalet, Barcelona, Spain. Gómez,MJ Servicio de Oncología, Hospital Puerta del Mar, Cádiz, Spain. Oltra,A Servicio de Oncología, Hospital Virgen de los Lirios, Alicante, Spain. Aranda,E Reina Sofía Hospital. University of Córdoba, Maimonides Institute of Biomedical Research (IMIBIC) Córdoba, Spain., Financial support for this research trial was provided by Roche Farma, S.A.

مصطلحات موضوعية: Capecitabine, Irinotecan, Camptothecin, Bevacizumab, Metastatic colorectal cancer, Chemotherapy, Protocolos de quimioterapia combinada antineoplásica, Camptotecina, Neoplasias colorrectales, Supervivencia sin enfermedad, Metástasis de la neoplasia, Resultado del tratamiento, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged::Aged, 80 and over, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols, Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Alkaloids::Camptothecin, Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Disease-Free Survival, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, Medical Subject Headings::Check Tags::Male, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged, Medical Subject Headings::Diseases::Neoplasms::Neoplastic Processes::Neoplasm Metastasis, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult, Medical Subject Headings::Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleosides::Pyrimidine Nucleosides::Cytidine::Deoxycytidine::Capecitabine

وصف الملف: application/pdf; application/vnd.oasis.opendocument.text

العلاقة: http://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-1293-y#Abs1Test; Garcia-Alfonso P, Chaves M, Muñoz A, Salud A, García-Gonzalez M, Grávalos C, et al. Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study. BMC Cancer. 2015; 15:327; http://hdl.handle.net/10668/2218Test; PMC4423590

الإتاحة: https://doi.org/10.1186/s12885-015-1293-yTest
http://hdl.handle.net/10668/2218Test

المؤلفون: Niki Karachaliou, Zoi Tsourti, Bartomeu Massuti, Santiago Ponce Aix, Martin Früh, Miklos Pless, Paolo Bidoli, Núria Jordana-Ariza, Ariadna Balada-Bel, H. Roschitzki-Voser, Enriqueta Felip, Solange Peters, Mónica Garzón-Ibáñez, Roswitha Kammler, Ramon Palmero, Sinead Cuffe, Clara Mayo-de-las-Casas, Rafael Rosell, Sanjay Popat, Enric Carcereny, M.A. Molina-Vila, Oliver Gautschi, Beatriz García-Peláez, Rolf A. Stahel, Urania Dafni, Alessandra Curioni Fontecedro

المساهمون: Molina-Vila, M, Stahel, R, Dafni, U, Jordana-Ariza, N, Balada-Bel, A, Garzón-Ibáñez, M, García-Peláez, B, Mayo-de-Las-Casas, C, Felip, E, Fontecedro, A, Gautschi, O, Peters, S, Massutí, B, Palmero, R, Aix, S, Carcereny, E, Früh, M, Pless, M, Popat, S, Cuffe, S, Bidoli, P, Kammler, R, Roschitzki-Voser, H, Tsourti, Z, Karachaliou, N, Rosell, R, University of Zurich, Stahel, Rolf A

المصدر: Journal of Thoracic Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Universidad de Alicante (UA)
JOURNAL OF THORACIC ONCOLOGY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-IGTP: Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

مصطلحات موضوعية: EGFR mutations in blood, NSCLC, Survival, cfDNA, 0301 basic medicine, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung Neoplasms, genetic structures, Survival, Bevacizumab, EGFR, 610 Medicine & health, NSCLC, Gastroenterology, Disease-Free Survival, 03 medical and health sciences, Exon, 0302 clinical medicine, Internal medicine, medicine, Humans, In patient, cfDNA, neoplasms, Protein Kinase Inhibitors, business.industry, EGFR mutations in blood, DNA, Confidence interval, respiratory tract diseases, ErbB Receptors, 030104 developmental biology, Real-time polymerase chain reaction, Oncology, Circulating free DNA, Egfr mutation, 2740 Pulmonary and Respiratory Medicine, 030220 oncology & carcinogenesis, Mutation, 10032 Clinic for Oncology and Hematology, 2730 Oncology, Erlotinib, Neoplasm Recurrence, Local, business, Cell-Free Nucleic Acids, medicine.drug

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::994673a7e864203d23813318e7ec156aTest
http://hdl.handle.net/10281/260723Test

المؤلفون: Barbara Ruepp, Paolo Bidoli, Margarita Majem, Niki Karachaliou, Martin Früh, David S. Shames, Enriqueta Felip, Rachel Tam, Oliver Gautschi, Roswitha Kammler, Patrizia Froesch, Javier Puente, Solange Peters, José Gómez-Codina, Rolf A. Stahel, Linda Coate, Rut Porta, Emer Hanrahan, Alessandra Curioni-Fontecedro, Urania Dafni, Ramon Palmero, Carlos Camps, Enric Carcereny, Rafael Rosell, Daniel Rauch, Sanjay Popat, Miguel Angel Molina-Vila, Michael Thomas, Manuela Rabaglio, Sinead Cuffe, M. Kassapian, Adolfo Favaretto, Riyaz Shah, Fabrice Barlesi, Miklos Pless, Bartomeu Massuti, Noemi Reguart, Athanasios Kotsakis, Santiago Ponce Aix

المساهمون: Rosell, R, Dafni, U, Felip, E, Curioni-Fontecedro, A, Gautschi, O, Peters, S, Massutí, B, Palmero, R, Aix, S, Carcereny, E, Früh, M, Pless, M, Popat, S, Kotsakis, A, Cuffe, S, Bidoli, P, Favaretto, A, Froesch, P, Reguart, N, Puente, J, Coate, L, Barlesi, F, Rauch, D, Thomas, M, Camps, C, Gómez-Codina, J, Majem, M, Porta, R, Shah, R, Hanrahan, E, Kammler, R, Ruepp, B, Rabaglio, M, Kassapian, M, Karachaliou, N, Tam, R, Shames, D, Molina-Vila, M, Stahel, R

المصدر: Lancet Respiratory Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Male, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, International Cooperation, Population, Proof of Concept Study, Disease-Free Survival, 03 medical and health sciences, T790M, Erlotinib Hydrochloride, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Medicine, Humans, 610 Medicine & health, education, Lung cancer, Response Evaluation Criteria in Solid Tumors, Aged, education.field_of_study, EGFR, NSCLC, business.industry, Middle Aged, Resistance mutation, medicine.disease, respiratory tract diseases, Surgery, Intention to Treat Analysis, ErbB Receptors, 030104 developmental biology, 030220 oncology & carcinogenesis, Mutation, Female, Erlotinib, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc716fb89940576072d11e1db6e24006Test
https://pubmed.ncbi.nlm.nih.gov/30636675Test

المؤلفون: Eduardo Díaz-Rubio, Auxiliadora Gómez-España, Bartomeu Massutí, Javier Sastre, Margarita Reboredo, José Luis Manzano, Fernando Rivera, M José Safont, Clara Montagut, Encarnación González, Manuel Benavides, Eugenio Marcuello, Andrés Cervantes, Purificación Martínez de Prado, Carlos Fernández-Martos, Antonio Arrivi, Inmaculada Bando, Enrique Aranda, Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD)

المساهمون: The Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD), [Díaz-Rubio,E, Sastre,J, Bando,I] Department of Medical Oncology, Hospital Clínico San Carlos (HCSC), Red Temática de Investigación Cooperativa en Cáncer (RD06/0020/0021), Facultad de Medicina, Universidad Complutense, Instituto de Investigación Sanitaria del HCSC (IdISSC), Madrid, Spain. [Gómez-España,A, Aranda,E] Department of Medical Oncology, Hospital Reina Sofía, Córdoba, Spain. [Massutí,B] Department of Medical Oncology, Hospital General, Alicante, Spain. [Reboredo,M] Department of Medical Oncology, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain. [Manzano, JL] Department of Medical Oncology, Instituto Catalán de Oncología, Hospital Germans Trias I Pujol, Badalona, Spain. [Rivera,F] Department of Medical Oncology, Hospital Marqués de Valdecilla, Santander, Spain. [Safont,MJ] Department of Medical Oncology, Hospital General de Valencia, Valencia, Spain. [Montagut,C] Department of Medical Oncology, Hospital del Mar, Barcelona, Spain. [González,E] Department of Medical Oncology, Hospital Virgen de las Nieves, Granada, Spain. [Benavides,M] Department of Medical Oncology, Hospital Universitario Carlos Haya, Málaga, Spain. [Marcuello,E] Department of Medical Oncology, Hospital Santa Creu i Sant Pau, Barcelona, Spain. [Cervantes,A] Department of Medical Oncology, Institute of Health Research INCLIVA. University of Valencia, Valencia, Spain. [Martínez de Prado, P] Department of Medical Oncology, Hospital de Basurto, Vizcaya, Spain. [Fernández-Martos, C] Department of Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain. [Arrivi,A] Department of Medical Oncology, Fundación Hospital Son Llatzer, Palma de Mallorca, Spain., This work was supported by Roche

المصدر: PLoS ONE, Vol 7, Iss 10, p e47345 (2012)
PLoS ONE

مصطلحات موضوعية: Male, Oncology, Organoplatinum Compounds, endocrine system diseases, Epidemiology, Colorectal cancer, Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings], Deoxycytidine, Metastasis, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Antineoplastic Combined Chemotherapy Protocols, Pathology, Medicine, Neoplasm Metastasis, genes, lcsh:Science, mediana edad, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [Medical Subject Headings], Aged, 80 and over, anciano, Chemicals and Drugs::Organic Chemicals::Organometallic Compounds::Organoplatinum Compounds [Medical Subject Headings], Cancer Risk Factors, Clinical Pharmacology, protocolos de quimioterapia antineoplásica combinada, Colon Adenocarcinoma, Pronóstico, Combination chemotherapy, adulto, Prognosis, Bevacizumab, Oxaliplatin, pronóstico, Oncology Agents, medicine.medical_specialty, Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation [Medical Subject Headings], Fluorouracilo, Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyrimidines::Pyrimidine Nucleosides::Cytidine::Deoxycytidine [Medical Subject Headings], Check Tags::Male [Medical Subject Headings], Molecular Genetics, Capecitabine, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized [Medical Subject Headings], Gastrointestinal Tumors, Genetics, Named Groups::Persons::Age Groups::Adult [Medical Subject Headings], Humans, Clinical Trials, Biology, neoplasms, Aged, lcsh:R, Diseases::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms [Medical Subject Headings], Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genes::Genes, Neoplasm::Oncogenes::Proto-Oncogenes::Genes, ras [Medical Subject Headings], medicine.disease, digestive system diseases, Check Tags::Female [Medical Subject Headings], Pharmacogenetics, Mutation, lcsh:Q, fluorouracilo, Multivariate analysis, Desoxicitidina, humanos, Cancer Treatment, Named Groups::Persons::Age Groups::Adult::Aged::Aged, 80 and over [Medical Subject Headings], lcsh:Medicine, medicine.disease_cause, Neoplasias colorrectales, Surgical oncology, Basic Cancer Research, Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyrimidines::Pyrimidinones::Uracil::Fluorouracil [Medical Subject Headings], Clinical Trials (Cancer Treatment), metástasis neoplásica, Metástasis neoplásica, Multidisciplinary, Middle Aged, Genetic Epidemiology, Protocolos de quimioterapia antineoplásica combinada, Female, Antiangiogenesis Therapy, Fluorouracil, KRAS, Colorectal Neoplasms, Research Article, medicine.drug, Adult, Drugs and Devices, Clinical Pathology, neoplasias colorrectales, Clinical Research Design, Genetic Causes of Cancer, Antibodies, Monoclonal, Humanized, Antibodies, Rectal Cancer, Antibody Therapy, Diagnostic Medicine, Internal medicine, Diseases::Neoplasms::Neoplastic Processes::Neoplasm Metastasis [Medical Subject Headings], Named Groups::Persons::Age Groups::Adult::Aged [Medical Subject Headings], mutación, Clinical Genetics, Mutación, business.industry, Pharmacoepidemiology, Cancers and Neoplasms, Human Genetics, Chemotherapy and Drug Treatment, desoxicitidina, Genes, ras, anticuerpos, Genetics of Disease, business, compuestos organoplatino

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4082e5022a58ff509dd9dd99c97af1eTest
https://doi.org/10.1371/journal.pone.0047345Test